Flunoxaprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H12FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UKU5U19W9M, chemically known as 5-benzoxazoleacetic acid, 2-(4-fluorophenyl)-alpha-methyl-, (s)- but generally known as flunoxaprofen, which bears US NIH Compound Identifier 68869. European Medicines Agency schedules Flunoxaprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07713MIG. The term FLUNOXAPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules flunoxaprofen in its Anatomical Therapeutic Chemical (ATC) Classification. FLUNOXAPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flunoxaprofen under HS 29349990 and SITC 51579. As of Q4 2014, FLUNOXAPROFEN remains the US FDA Preferred Term for this commodity. Flunoxaprofen bears US NLM identifiers UMLS ID C0060504 and NCI Concept Code C65722. SMILES: FC1CCC(C2OC3C(N2)CC(C(C)C(=O)O)CC3)CC1.